Resources:
On 21 September 2022, the RWE4Decisions community gathered for a multi-stakeholder discussion on HealthData in Germany, with a focus on the routine data collection practice (AbD) at the Federal Joint Committee (G-BA). The panel featured representation of HTA bodies, patients, insurers and industry.
Administrator Général Honoraire, National Institute for Health and Disability Insurance (INAMI-RIZIV), Belgium
Pharmaeconomist, Finnish Medicines Agency (Fimea)
Advisory member at the General Directorate of the Common NHS Services Portfolio and Pharmacy, Spanish Ministry of Health
Senior Medical Advisor at France Assos Santé and Scientific Committee Member as Patients Associations representative at HAS
This was the second public webinar to update on how countries are developing their data environments in a way that could be useful for HTA bodies and Payers, to support additional data collection.
Public Webinar: From Policy to Practice: EHDS Implementation to Support Better Real-World Evidence for HTA/Payers
RWE4Decisions Symposium: Developing Real-World Evidence to Deliver Innovation in HTA
Public Webinar: HTA/Payer Collaboration in the Nordics: The Role of Real-World Evidence
